InsidersTradesSigma
Track the 华北制药 share price and the full insider trade history of the company, a listed issuer based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 华北制药 has logged 1 public disclosures. Market capitalisation: €8.2bn. The latest transaction was disclosed on 24 February 2025 (Purchase). Among the most active insiders: 吕伟. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
华北制药是一家在中国专业生产医药产品的公司。它在上海证券交易所上市。